European Pharmaceutical Review
APRIL 4, 2025
Stability tests are designed to assess the percentage of the active substance throughout the products shelf life and provide insight into any degradation that may occur within the final dosage form. For solid dosage forms, including capsules, tablets, or film-coated tablets, dissolution tests are conducted.
Pharma Marketing Network
JULY 18, 2025
AI-Powered Omnichannel Engagement With AI, pharma marketers can coordinate messaging across email, webinars, display ads, and even voice assistants. Today, AI uses real-time analytics to serve dynamic content that adapts based on individual preferences and behaviors. Furthermore, personalization now extends to patient-facing communications.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 27, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Pharmacy Times
JUNE 25, 2025
It will be interesting to see what dosage form these data prompt the future development of. It also introduces a question on how to optimize the PK/pharmacodynamic profile for protein degraders, such as cereblon E3 ligase modulatory drugs and proteolysis-targeting chimeras, which are a burgeoning area of therapeutic development.”
Pharma Marketing Network
JUNE 3, 2025
Today, digital-first strategies dominate, emphasizing email marketing, display ads, social media, webinars, and branded content. For instance, CTAs that lead to clinical trial data, peer-reviewed studies, or expert webinars offer real value and respect physicians time constraints. What makes a good CTA for HCPs?
PharmaVoice
JUNE 27, 2025
Other PrEP regimens on the market require daily oral dosages or shots every few months, but the latest version is only administered twice a year. The FDA approved the updated formulation, which will be sold under the brand name Yeztugo, earlier this month.
Pharmacy Times
JULY 12, 2025
Animal studies reveal dose-dependent hepatic responses to CBD, supporting the need for cautious monitoring even at consumer-relevant dosages. Clinical trials show low-dose CBD can cause significant liver enzyme elevations in 5.6% of healthy adults, necessitating liver function monitoring.
Expert insights. Personalized for you.
64 
Let's personalize your content